AptarGroup, Inc (NYSE:ATR) Accelerates Product Protection Rollouts While Valuation Remains Elevated

AptarGroup shows near-term technical recovery potential as product innovation and a steady dividend cadence reinforce operational momentum. Valuation metrics, however, register above peers and constrain longer-duration upside.

Recent News

On July 8, 2025 Aptar announced a new dual-active material science technology engineered to control moisture and oxygen simultaneously for pharmaceutical drugs and medical devices, extending its Activ-Polymer™ platform into broader stability use cases. On July 10, 2025 Aptar declared a quarterly cash dividend of $0.45 per share, payable August 14, 2025 to holders of record July 24, 2025; the company scheduled its Q2 2025 conference call for August 1, 2025.

Technical Analysis

Directional strength: ADX at 27.71 signals a strong trend environment while DI+ has conducted a dip-and-reverse and DI- a peak-and-reverse; both directional readings point toward short-term bullish momentum relative to recent price action.

MACD: MACD sits at -2.11 with a dip-and-reverse pattern and currently trades above its signal line (-2.45), indicating bullish momentum has started to develop despite negative absolute MACD values.

MRO (Momentum/Regression Oscillator): MRO at -25.1 indicates price sits below WMDST’s target and therefore carries upside potential; the dip-and-reverse in MRO supports an expected convergence toward that target in the near term.

RSI: RSI at 38.76 with a dip-and-reverse points to improving momentum from a lower base; momentum recovery may accelerate if RSI moves through neutral territory.

Price vs. averages and cloud: Last close $133.18 sits below the 200-day average ($148.61) and the 50-day average ($139.78), signaling medium-term underperformance, while the 12-day EMA (price12dayEMA $133.49) shows a dip-and-reverse consistent with short-term recovery attempts. Ichimoku Senkou A ($145.12) and Senkou B ($150.36) remain above price, indicating the cloud keeps a restraint on sustained advances.

Bands, volatility and volume: Price trades inside the Bollinger 1x band (lower $131.75 / upper $134.85) near the lower band, implying limited downside room in the immediate session; 10-day volume sits modestly below its 10- and 50-day averages, so conviction behind moves remains moderate. SuperTrend upper boundary at $136.63 offers a nearby technical resistance level to monitor.

 


Fundamental Analysis

Profitability and margins: EBIT $150,564,000 and EBITDA $220,468,000. EBIT margin at 15.59% improved QoQ (up 17.84%) and YoY (up 10.55%), and stands above the industry peer range (industry peer high ~12.58%), indicating stronger operating profitability versus peers.

Revenue and earnings: Total revenue $966,009,000 with YoY revenue growth reported at -16.09% and QoQ revenue growth at 91.83%; net income $111,720,000. EPS actual $1.66 versus estimate $1.59, producing an EPS surprise of +4.40%.

Cash generation and liquidity: Operating cash flow $125,958,000 and free cash flow $61,002,000 produce a free cash flow yield of 0.63%; cash conversion metrics and a cash flow-to-earnings ratio of 71.79% demonstrate material cash backing of reported earnings, while the cash ratio sits near 12.40% and the quick ratio at 0.83.

Leverage and coverage: Total debt $1,136,237,000 with net debt $924,849,000. Debt-to-assets 23.35% and debt-to-equity 42.08% lie below the industry peer means, while interest coverage 13.88x remains well above the industry peer mean, indicating a conservative leverage posture and strong ability to service interest.

Efficiency and returns: Asset turnover 0.2057 modestly exceeds the industry peer mean, and return on equity registers 4.14% with return on assets 2.38%; ROE sits below the industry peer mean but within the broader peer range. Inventory and receivables turnover show modest movement QoQ.

Valuation multiples: Price-to-earnings stands at 93.34x, price-to-book 3.59x, price-to-sales 10.03x, forward PE ~102.63x and enterprise multiple ~48.33x. WMDST values the stock as over-valued, reflecting these elevated multiples versus expected cash conversion and return metrics.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-07-31
NEXT REPORT DATE: 2025-10-31
CASH FLOW  Begin Period Cash Flow 125.8 M
 Operating Cash Flow 126.0 M
 Capital Expenditures -64.96 M
 Change In Working Capital -43.90 M
 Dividends Paid -29.72 M
 Cash Flow Delta 35.9 M
 End Period Cash Flow 161.7 M
 
INCOME STATEMENT REVENUE
 Total Revenue 966.0 M
 Forward Revenue 210.9 M
COSTS
 Cost Of Revenue 599.0 M
 Depreciation 58.8 M
 Depreciation and Amortization 69.9 M
 Research and Development
 Total Operating Expenses 820.0 M
PROFITABILITY
 Gross Profit 367.0 M
 EBITDA 220.5 M
 EBIT 150.6 M
 Operating Income 146.0 M
 Interest Income 1.9 M
 Interest Expense 10.8 M
 Net Interest Income -8.97 M
 Income Before Tax 139.7 M
 Tax Provision 28.0 M
 Tax Rate 20.0 %
 Net Income 111.7 M
 Net Income From Continuing Operations 111.7 M
EARNINGS
 EPS Estimate 1.59
 EPS Actual 1.66
 EPS Difference 0.07
 EPS Surprise 4.403 %
 Forward EPS 1.48
 
BALANCE SHEET ASSETS
 Total Assets 4.9 B
 Intangible Assets 1.2 B
 Net Tangible Assets 1.5 B
 Total Current Assets 1.7 B
 Cash and Short-Term Investments 169.8 M
 Cash 161.7 M
 Net Receivables 800.2 M
 Inventory 527.4 M
 Long-Term Investments 150.3 M
LIABILITIES
 Accounts Payable
 Short-Term Debt 551.5 M
 Total Current Liabilities 1.4 B
 Net Debt 924.8 M
 Total Debt 1.1 B
 Total Liabilities 2.1 B
EQUITY
 Total Equity 2.7 B
 Retained Earnings 2.5 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 41.04
 Shares Outstanding 65.800 M
 Revenue Per-Share 14.68
VALUATION
 Market Capitalization 9.7 B
 Enterprise Value 10.7 B
 Enterprise Multiple 48.332
Enterprise Multiple QoQ -17.209 %
Enterprise Multiple YoY -3.072 %
Enterprise Multiple IPRWA ATR: 48.332
high: 42.857
median: 41.489
mean: 38.156
low: 32.485
 EV/R 11.031
CAPITAL STRUCTURE
 Asset To Equity 1.802
 Asset To Liability 2.266
 Debt To Capital 0.296
 Debt To Assets 0.234
Debt To Assets QoQ -0.013 %
Debt To Assets YoY 156.328 %
Debt To Assets IPRWA high: 0.537
median: 0.463
mean: 0.442
low: 0.378
ATR: 0.234
 Debt To Equity 0.421
Debt To Equity QoQ 0.986 %
Debt To Equity YoY 148.559 %
Debt To Equity IPRWA high: 2.319
mean: 1.814
median: 1.759
low: 1.35
ATR: 0.421
PRICE-BASED VALUATION
 Price To Book (P/B) 3.588
Price To Book QoQ -6.735 %
Price To Book YoY -9.054 %
Price To Book IPRWA high: 4.04
ATR: 3.588
mean: 2.869
median: 2.856
low: 1.393
 Price To Earnings (P/E) 93.343
Price To Earnings QoQ -24.32 %
Price To Earnings YoY -10.334 %
Price To Earnings IPRWA ATR: 93.343
high: 73.755
mean: 56.227
median: 53.885
low: 33.16
 PE/G Ratio 2.435
 Price To Sales (P/S) 10.03
Price To Sales QoQ -8.845 %
Price To Sales YoY -3.464 %
Price To Sales IPRWA ATR: 10.03
high: 4.454
median: 3.709
mean: 3.692
low: 2.306
FORWARD MULTIPLES
Forward P/E 102.631
Forward PE/G 2.677
Forward P/S 45.949
EFFICIENCY OPERATIONAL
 Operating Leverage 3.189
ASSET & SALES
 Asset Turnover Ratio 0.206
Asset Turnover Ratio QoQ 3.852 %
Asset Turnover Ratio YoY 0.474 %
Asset Turnover Ratio IPRWA high: 0.222
ATR: 0.206
mean: 0.191
median: 0.182
low: 0.155
 Receivables Turnover 1.252
Receivables Turnover Ratio QoQ -1.161 %
Receivables Turnover Ratio YoY 0.565 %
Receivables Turnover Ratio IPRWA high: 2.929
mean: 2.158
median: 1.996
low: 1.365
ATR: 1.252
 Inventory Turnover 1.185
Inventory Turnover Ratio QoQ 1.675 %
Inventory Turnover Ratio YoY 2.481 %
Inventory Turnover Ratio IPRWA high: 2.516
median: 1.544
mean: 1.543
ATR: 1.185
low: 1.072
 Days Sales Outstanding (DSO) 72.873
CASH CYCLE
 Cash Conversion Cycle Days (CCC)
Cash Conversion Cycle Days QoQ
Cash Conversion Cycle Days YoY
Cash Conversion Cycle Days IPRWA
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 3.284
 CapEx To Revenue -0.067
 CapEx To Depreciation -1.104
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 3.2 B
 Net Invested Capital 3.8 B
 Invested Capital 3.8 B
 Net Tangible Assets 1.5 B
 Net Working Capital 294.1 M
LIQUIDITY
 Cash Ratio 0.124
 Current Ratio 1.215
Current Ratio QoQ -2.922 %
Current Ratio YoY -10.953 %
Current Ratio IPRWA high: 1.266
ATR: 1.215
mean: 1.063
median: 0.999
low: 0.96
 Quick Ratio 0.83
Quick Ratio QoQ -2.538 %
Quick Ratio YoY -12.623 %
Quick Ratio IPRWA high: 0.955
ATR: 0.83
mean: 0.69
median: 0.669
low: 0.558
COVERAGE & LEVERAGE
 Debt To EBITDA 5.154
 Cost Of Debt 0.791 %
 Interest Coverage Ratio 13.877
Interest Coverage Ratio QoQ 34.209 %
Interest Coverage Ratio YoY 8.813 %
Interest Coverage Ratio IPRWA ATR: 13.877
high: 4.309
median: 3.845
mean: 3.792
low: 2.645
 Operating Cash Flow Ratio 0.059
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO)
DIVIDENDS
 Dividend Coverage Ratio 3.759
 Dividend Payout Ratio 0.266
 Dividend Rate 0.45
 Dividend Yield 0.003
PERFORMANCE GROWTH
 Asset Growth Rate 7.473 %
 Revenue Growth 8.87 %
Revenue Growth QoQ 91.825 %
Revenue Growth YoY -1608.503 %
Revenue Growth IPRWA high: 11.772 %
ATR: 8.87 %
mean: 8.369 %
median: 7.782 %
low: 4.943 %
 Earnings Growth 38.333 %
Earnings Growth QoQ -282.079 %
Earnings Growth YoY 339.095 %
Earnings Growth IPRWA high: 205.128 %
mean: 52.86 %
ATR: 38.333 %
median: 23.171 %
low: 20.635 %
MARGINS
 Gross Margin 37.993 %
Gross Margin QoQ 0.208 %
Gross Margin YoY 0.916 %
Gross Margin IPRWA ATR: 37.993 %
high: 23.057 %
mean: 20.872 %
median: 19.432 %
low: 19.413 %
 EBIT Margin 15.586 %
EBIT Margin QoQ 17.835 %
EBIT Margin YoY 10.547 %
EBIT Margin IPRWA ATR: 15.586 %
high: 12.575 %
mean: 10.811 %
median: 10.455 %
low: 8.573 %
 Return On Sales (ROS) 15.111 %
Return On Sales QoQ 14.244 %
Return On Sales YoY 7.178 %
Return On Sales IPRWA ATR: 15.111 %
high: 13.909 %
mean: 11.472 %
median: 10.665 %
low: 8.573 %
CASH FLOW
 Free Cash Flow (FCF) 61.0 M
 Free Cash Flow Yield 0.63 %
Free Cash Flow Yield QoQ 162.5 %
Free Cash Flow Yield YoY -20.954 %
Free Cash Flow Yield IPRWA high: 3.365 %
median: 1.587 %
mean: 1.361 %
ATR: 0.63 %
low: -5.481 %
 Free Cash Growth 160.637 %
Free Cash Growth QoQ -305.234 %
Free Cash Growth YoY -54.377 %
Free Cash Growth IPRWA ATR: 160.637 %
high: -61.606 %
median: -131.635 %
mean: -732.714 %
low: -2168.421 %
 Free Cash To Net Income 0.546
 Cash Flow Margin 8.302 %
 Cash Flow To Earnings 0.718
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 2.379 %
Return On Assets QoQ 35.247 %
Return On Assets YoY 16.904 %
Return On Assets IPRWA high: 4.003 %
ATR: 2.379 %
mean: 1.456 %
median: 1.157 %
low: 0.709 %
 Return On Capital Employed (ROCE) 4.306 %
 Return On Equity (ROE) 0.041
Return On Equity QoQ 33.269 %
Return On Equity YoY 9.616 %
Return On Equity IPRWA high: 0.152
mean: 0.058
ATR: 0.041
median: 0.041
low: 0.022
 DuPont ROE 4.266 %
 Return On Invested Capital (ROIC) 3.18 %
Return On Invested Capital QoQ 29.426 %
Return On Invested Capital YoY -94.109 %
Return On Invested Capital IPRWA ATR: 3.18 %
high: 3.098 %
mean: 2.239 %
median: 2.204 %
low: 1.233 %

Six-Week Outlook

Near-term technical signals favor a rebound: directional indicators, a MACD crossover above its signal line, negative MRO with a dip-and-reverse, and an improving RSI all indicate momentum toward higher prices over the next several weeks. Price remains below the 50- and 200-day averages and beneath the Ichimoku cloud, which suggests that any rally may meet meaningful resistance and could lack follow-through unless accompanied by stronger volume or a shift in longer-term averages.

Given elevated valuation metrics and modest free cash flow yield, expect rallies to encounter resistance around the upper short-term band and SuperTrend upper boundary; downside risk stays contained while momentum recovers, but sustained upside will require improvement in cash generation or a re-rating of multiples. Monitor momentum cross-confirmation (MACD sustaining above its signal and MRO moving toward zero) and changes in volume for clarity on sustainment over the six-week horizon.

About AptarGroup, Inc.

AptarGroup, Inc. (NYSE:ATR) designs and manufactures innovative solutions for drug delivery, consumer product dispensing, and active material science. The company serves diverse markets, including pharmaceuticals, beauty, personal care, home care, and food and beverage. AptarGroup operates through three primary segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. Aptar Pharma develops advanced delivery systems for medications, providing products such as nasal pumps and metered dose inhaler valves, which assist in managing respiratory conditions like asthma. Aptar Beauty delivers elegant and functional dispensing solutions for cosmetics and skincare products. Aptar Closures creates innovative closures and dispensing systems for food and beverage products. Committed to sustainability and innovation, AptarGroup employs cutting-edge material science to produce solutions that are both effective and environmentally friendly. Headquartered in Crystal Lake, Illinois, the company maintains a global presence across Asia, Europe, Latin America, and North America, catering to a diverse clientele. Since its incorporation in 1992, AptarGroup has played a key role in transforming product delivery and enhancing user experiences worldwide.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.